EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population‐based study

Yifei Ren, Yuanjing Li, Na Tian, Rui Liu, Yi Dong, Tingting Hou, Cuicui Liu, Xiaolei Han, Xiaodong Han, Lidan Wang, Davide Liborio Vetrano, Tiia Ngandu und 6 weitere

Alzheimer's & Dementia · 2024-03 · 20 (3) · 1550-1561

DOI: 10.1002/alz.13519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 02.12.2023. Verfasst von Yifei Ren und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Dementia, Vascular. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION To examine the burden and clusters of multimorbidity in association with mild cognitive impairment (MCI), dementia, and Alzheimer's disease (AD)‐related plasma biomarkers among older adults. METHODS This population‐based study included 5432 participants (age ≥60 years); of these, plasma amyloid beta (Aβ), total tau, and neurofilament light chain (NfL) were measured in a subsample ( n = 1412). We used hierarchical clustering to generate five multimorbidity clusters from 23 chronic diseases. We diagnosed dementia and MCI following international criteria. Data were analyzed using logistic and linear regression models. RESULTS The number of chronic diseases was associated with dementia (multivariable‐adjusted odds ratio = 1.22; 95% confidence interval [CI] = 1.11 to 1.33), AD (1.13; 1.01 to 1.26), vascular dementia (VaD) (1.44; 1.25 to 1.64), and non‐amnestic MCI (1.25; 1.13 to 1.37). Metabolic cluster was associated with VaD and non‐amnestic MCI, whereas degenerative ocular cluster was associated with AD ( p < 0.05). The number of chronic diseases was associated with increased plasma Aβ and NfL ( p < 0.05). DISCUSSION Multimorbidity burden and clusters are differentially associated with subtypes of dementia and MCI and AD‐related plasma biomarkers in older adults. Highlights We used hierarchical clustering to generate five clusters of multimorbidity. The presence and load of multimorbidity were associated with dementia and mild cognitive impairment. Multimorbidity clusters were differentially associated with subtypes of dementia and Alzheimer's disease plasma biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionDementia, VascularHumansAgedMiddle AgedAmyloid beta-PeptidesMultimorbidityDisease ProgressionBiomarkersPhenotypeChronic DiseaseCognitiontau Proteins

Stichwörter der Autor:innen

dementiamild cognitive impairmentmultimorbidityplasma biomarkerspopulation-based studyrural

Substanzen

Amyloid beta-PeptidesBiomarkerstau Proteins

Autor:innen und Institutionen

  • Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
  • Aging Research Center and Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University, Solna, Sweden.
  • Department of Neurology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, P. R. China.
  • Shandong Provincial Clinical Research Center for Geriatric Neurological Diseases, Jinan, Shandong, P. R. China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, P. R. China.
  • Stockholm Gerontology Research Center, Stockholm, Sweden.

ORCID-Profile: Yifeng Du

Förderung

  • STI2030-Major Projects
  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Provincial Natural Science Foundation of Shandong
  • Integrated Traditional Chinese and Western Medicine Program in Shandong Province
  • Academic Promotion Program of Shandong First Medical University
  • Shandong Provincial Key Research and Development Program
  • Swedish Research Council

Zitieren

APA

Ren, Y., Li, Y., Tian, N., Liu, R., Dong, Y., Hou, T., Liu, C., Han, X., Han, X., Wang, L., Vetrano, D. L., Ngandu, T., Marengoni, A., Kivipelto, M., Wang, Y., Cong, L., Du, Y., & Qiu, C. (2024). Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population‐based study. Alzheimer's & Dementia, 20(3), 1550-1561. https://doi.org/10.1002/alz.13519

Vancouver

Ren Y, Li Y, Tian N, Liu R, Dong Y, Hou T, et al. Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population‐based study. Alzheimer's & Dementia. 2024;20(3):1550-1561. doi:10.1002/alz.13519

BibTeX
@article{Ren2024,
  author = {Ren, Yifei and Li, Yuanjing and Tian, Na and Liu, Rui and Dong, Yi and Hou, Tingting and Liu, Cuicui and Han, Xiaolei and Han, Xiaodong and Wang, Lidan and Vetrano, Davide Liborio and Ngandu, Tiia and Marengoni, Alessandra and Kivipelto, Miia and Wang, Yongxiang and Cong, Lin and Du, Yifeng and Qiu, Chengxuan},
  title = {Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population‐based study},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {3},
  pages = {1550--1561},
  doi = {10.1002/alz.13519}
}
Kostenlos starten →